Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants

ABSTRACT Candida albicans is part of normal microbiota; however, it can cause superficial and life-threatening infections in immune-compromised individuals. As the use of drugs from the echinocandin (ECN) class for the treatment of candidiasis is increasing, resistance against ECNs is also emerging....

Full description

Bibliographic Details
Main Authors: Sudisht K. Sah, Anshuman Yadav, Michael D. Kruppa, Elena Rustchenko
Format: Article
Language:English
Published: American Society for Microbiology 2023-12-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.03295-23
_version_ 1797393611173658624
author Sudisht K. Sah
Anshuman Yadav
Michael D. Kruppa
Elena Rustchenko
author_facet Sudisht K. Sah
Anshuman Yadav
Michael D. Kruppa
Elena Rustchenko
author_sort Sudisht K. Sah
collection DOAJ
description ABSTRACT Candida albicans is part of normal microbiota; however, it can cause superficial and life-threatening infections in immune-compromised individuals. As the use of drugs from the echinocandin (ECN) class for the treatment of candidiasis is increasing, resistance against ECNs is also emerging. We identified 10 genes on C. albicans chromosome 5 (Ch5) that are simultaneously downregulated to decrease susceptibility to ECN caspofungin. Independent knock-out experiments demonstrated that these genes act overall to decrease the 1,3-β-glucan level in the cell wall, change levels of mannan and chitin, and affect expression of FKS genes. Importantly, 10 genes on Ch5 increase or decrease surface exposure of the immunogenic epitope 1,3-β-glucan. Our data indicate functions for previously uncharacterized orf19.970 and orf19.4149.1, of which orf19.970 has no human ortholog. Our data also indicate new functions for the genes DUS4, RPS25B, UAP1, URA7, RPO26, HAS1, and CKS1, whereas the function of CHT2 as a negative regulator of ECN susceptibility has been previously established. Importantly, half of the above genes are essential; hence, indispensable processes are involved in the adaptation to ECNs. Our results suggest that a novel group of genes works in concert to control adaptation to ECNs and point to potential new drug targets. IMPORTANCE Candida infections are often fatal in immuno-compromised individuals, resulting in many thousands of deaths per year. Caspofungin has proven to be an excellent anti-Candida drug and is now the frontline treatment for infections. However, as expected, the number of resistant cases is increasing; therefore, new treatment modalities are needed. We are determining metabolic pathways leading to decreased drug susceptibility in order to identify mechanisms facilitating evolution of clinical resistance. This study expands the understanding of genes that modulate drug susceptibility and reveals new targets for the development of novel antifungal drugs.
first_indexed 2024-03-09T00:06:21Z
format Article
id doaj.art-82691a61fba941f7aad9bc5069b7a97b
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-09T00:06:21Z
publishDate 2023-12-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-82691a61fba941f7aad9bc5069b7a97b2023-12-12T13:17:19ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-12-0111610.1128/spectrum.03295-23Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutantsSudisht K. Sah0Anshuman Yadav1Michael D. Kruppa2Elena Rustchenko3Department of Biochemistry and Biophysics, University of Rochester Medical Center , Rochester, New York, USADepartment of Biochemistry and Biophysics, University of Rochester Medical Center , Rochester, New York, USADepartment of Biomedical Sciences, Center of Excellence in Inflammation, Infectious Disease and Immunity, Quillen College of Medicine, East Tennessee State University , Johnson City, Tennessee, USADepartment of Biochemistry and Biophysics, University of Rochester Medical Center , Rochester, New York, USAABSTRACT Candida albicans is part of normal microbiota; however, it can cause superficial and life-threatening infections in immune-compromised individuals. As the use of drugs from the echinocandin (ECN) class for the treatment of candidiasis is increasing, resistance against ECNs is also emerging. We identified 10 genes on C. albicans chromosome 5 (Ch5) that are simultaneously downregulated to decrease susceptibility to ECN caspofungin. Independent knock-out experiments demonstrated that these genes act overall to decrease the 1,3-β-glucan level in the cell wall, change levels of mannan and chitin, and affect expression of FKS genes. Importantly, 10 genes on Ch5 increase or decrease surface exposure of the immunogenic epitope 1,3-β-glucan. Our data indicate functions for previously uncharacterized orf19.970 and orf19.4149.1, of which orf19.970 has no human ortholog. Our data also indicate new functions for the genes DUS4, RPS25B, UAP1, URA7, RPO26, HAS1, and CKS1, whereas the function of CHT2 as a negative regulator of ECN susceptibility has been previously established. Importantly, half of the above genes are essential; hence, indispensable processes are involved in the adaptation to ECNs. Our results suggest that a novel group of genes works in concert to control adaptation to ECNs and point to potential new drug targets. IMPORTANCE Candida infections are often fatal in immuno-compromised individuals, resulting in many thousands of deaths per year. Caspofungin has proven to be an excellent anti-Candida drug and is now the frontline treatment for infections. However, as expected, the number of resistant cases is increasing; therefore, new treatment modalities are needed. We are determining metabolic pathways leading to decreased drug susceptibility in order to identify mechanisms facilitating evolution of clinical resistance. This study expands the understanding of genes that modulate drug susceptibility and reveals new targets for the development of novel antifungal drugs.https://journals.asm.org/doi/10.1128/spectrum.03295-23Candida albicanscaspofungin adaptationcell wall remodeling1,3-β-glucan exposurechromosome 5 genes
spellingShingle Sudisht K. Sah
Anshuman Yadav
Michael D. Kruppa
Elena Rustchenko
Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants
Microbiology Spectrum
Candida albicans
caspofungin adaptation
cell wall remodeling
1,3-β-glucan exposure
chromosome 5 genes
title Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants
title_full Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants
title_fullStr Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants
title_full_unstemmed Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants
title_short Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants
title_sort identification of 10 genes on candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β glucan and cell wall remodeling in caspofungin adapted mutants
topic Candida albicans
caspofungin adaptation
cell wall remodeling
1,3-β-glucan exposure
chromosome 5 genes
url https://journals.asm.org/doi/10.1128/spectrum.03295-23
work_keys_str_mv AT sudishtksah identificationof10genesoncandidaalbicanschromosome5thatcontrolsurfaceexposureoftheimmunogeniccellwallepitopebglucanandcellwallremodelingincaspofunginadaptedmutants
AT anshumanyadav identificationof10genesoncandidaalbicanschromosome5thatcontrolsurfaceexposureoftheimmunogeniccellwallepitopebglucanandcellwallremodelingincaspofunginadaptedmutants
AT michaeldkruppa identificationof10genesoncandidaalbicanschromosome5thatcontrolsurfaceexposureoftheimmunogeniccellwallepitopebglucanandcellwallremodelingincaspofunginadaptedmutants
AT elenarustchenko identificationof10genesoncandidaalbicanschromosome5thatcontrolsurfaceexposureoftheimmunogeniccellwallepitopebglucanandcellwallremodelingincaspofunginadaptedmutants